First People's Hospital

Company snapshot

First People's Hospital maintains 1136 tracked programs across Acute Myeloid Leukemia, Breast Cancer, Gastric Cancer, Multiple Myeloma, Esophageal Squamous Cell Carcinoma, Acute Ischemic Stroke, Prostate Cancer, Esophageal Cancer, Non-small Cell Lung Cancer, Hepatocellular Carcinoma, Nasopharyngeal Carcinoma, Hypertension. Momentum score: 20/100 (30-day delta: n/a). Public registry data covers pip

• 1136 active pipeline program(s) linked via ClinicalTrials.gov.
• 123 US patent(s) indexed to this assignee profile.
• 1136 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for First People's Hospital. Not investment advice.

• Peer + 0 momentum

  Chinese Academy of

  TA overlap score 70

• Peer + 0 momentum

  Chongqing Precision Biotech

  TA overlap score 50

• Peer + 0 momentum

  Hospital Authority

  TA overlap score 50

• Peer + 0 momentum

  Takeda

  TA overlap score 40

• Peer + 0 momentum

  Teva Pharma

  TA overlap score 40

• Peer + 0 momentum

  Novartis India

  TA overlap score 40

• Peer + 0 momentum

  AbbVie Deutschland GmbH

  TA overlap score 40

• Peer + 0 momentum

  HOFFMANN-LA ROCHE

  TA overlap score 40

• Peer + 0 momentum

  United Therapeutics Europe

  TA overlap score 40

• Peer + 0 momentum

  Regeneron UK

  TA overlap score 40

Recent activity

Latest pipeline, patent, and corporate events for First People's Hospital.

1. Jun 8, 2026 Clinical update

   XMDYYYXYK-12 — Phase 2

2. Jun 8, 2026 Clinical update

   2025-SR-813 — Phase 2

3. Jun 8, 2026 Clinical update

   13914704178 — Phase 2

4. Jun 8, 2026 Clinical update

   09 — Phase 3

5. Jun 8, 2026 Clinical update

   Ommaya 02 — Phase 2

View all clinical trial activity →

• What is First People's Hospital?

  First People's Hospital is a pharma organization headquartered in SAN DIEGO, CA, CN. Primary therapeutic focus areas include Acute Myeloid Leukemia, Breast Cancer, Gastric Cancer, Multiple Myeloma, Esophageal Squamous Cell Carcinoma. NovaPharmaNews links 1136 clinical program(s),

• Is First People's Hospital publicly traded?

  First People's Hospital appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does First People's Hospital develop or market?

  We link 626 drug profile(s) where First People's Hospital is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/first-tracks-biotherapeutics#company-drugs.

• What are the latest developments for First People's Hospital?

  In the last 12 months our linked public records show 1136 trial program update(s) and 1 US patent grant(s) tied to this profile.

• What therapeutic areas does First People's Hospital focus on?

  First People's Hospital focuses on Acute Myeloid Leukemia, Breast Cancer, Gastric Cancer based on our analysis of their pipeline programs and drug development activities.